| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Oruka Therapeutics, Inc. (ORKA) has 8 insiders with recent SEC Form 4 filings, including 1 buy and 9 sells. ORKA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 1.13M | $73.37M | - | |
| COO | 206.2K | $13.37M | - | |
| Other | 36.1K | $2.34M | -7,000 | |
| Dir | 35.0K | $2.27M | - | |
| Dir | 17.5K | $1.13M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 26, 2018 | Mott David M88 | 10% Owner | Sell | 1,460,209 | $0.50 | $731,272.67 | -100% | |
| Feb 26, 2018 | Baskett Forest53 | 10% Owner | Sell | 1,460,209 | $0.50 | $731,272.67 | -100% | |
| Feb 26, 2018 | Barris Peter J | 10% Owner | Sell | 1,460,209 | $0.50 | $731,272.67 | -100% | |
| Feb 26, 2018 | Makower Joshua | 10% Owner | Sell | 1,460,209 | $0.50 | $731,272.67 | -100% | |
| Feb 26, 2018 | Florence Anthony A. Jr.57 | 10% Owner | Sell | 1,460,209 | $0.50 | $731,272.67 | -100% | |
| Feb 26, 2018 | Growth Equity Opportunities Iv, LLC | 10% Owner | Sell | 1,460,209 | $0.50 | $731,272.67 | -100% | |
| Feb 26, 2018 | Viswanathan Ravi | 10% Owner | Sell | 1,460,209 | $0.50 | $731,272.67 | -100% | |
| Feb 26, 2018 | Sonsini Peter W. | 10% Owner | Sell | 1,460,209 | $0.50 | $731,272.67 | -100% | |
| Feb 26, 2018 | Sandell Scott D56 | 10% Owner | Sell | 1,460,209 | $0.50 | $731,272.67 | -100% | |
| Jul 14, 2017 | Conway Robert E | Director, Chairman Of The Board | Buy | 10,000 | $2.49 | $24,900.00 | +40.0% |